Hariharan S, Israni AK, Danovitch G (2021) Long-term survival after kidney transplantation. N Engl J Med 385:729–743. https://doi.org/10.1056/nejmra2014530

Article  CAS  PubMed  Google Scholar 

Van Arendonk KJ, Boyarsky BJ, Orandi BJ et al (2014) National trends over 25 years in pediatric kidney transplant outcomes. Pediatrics 133:594–601. https://doi.org/10.1542/peds.2013-2775

Article  PubMed  PubMed Central  Google Scholar 

Alkandari O, Nguyen L, Hebert D, Langlois V, Jawa NA, Parekh RS, Robinson LA (2018) Acute kidney injury in children with kidney transplantation. Clin J Am Soc Nephrol 13:1721–1729. https://doi.org/10.2215/CJN.02440218

Article  PubMed  PubMed Central  Google Scholar 

Wen Y, Parikh CR (2021) Current concepts and advances in biomarkers of acute kidney injury. Crit Rev Clin Lab Sci 58:354–368. https://doi.org/10.1080/10408363.2021.1879000

Article  CAS  PubMed  Google Scholar 

Filler G (2007) Calcineurin inhibitors in pediatric renal transplant recipients. Pediatr Drugs 9:165–174. https://doi.org/10.2165/00148581-200709030-00005

Article  Google Scholar 

Filler G (2006) Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation. Pediatr Transplant 10:707–711. https://doi.org/10.1111/j.1399-3046.2006.00553.x

Article  CAS  PubMed  Google Scholar 

Tönshoff B, David-Neto E, Ettenger R, Filler G, van Gelder T, Goebel J, Kuypers DR, Tsai E, Vinks AA, Weber LT, Zimmerhackl LB (2011) Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation. Transplant Rev 25:78–89. https://doi.org/10.1016/j.trre.2011.01.001

Article  Google Scholar 

Balani SS, Jensen CJ, Kouri AM, Kizilbash SJ (2021) Induction and maintenance immunosuppression in pediatric kidney transplantation-advances and controversies. Pediatr Transplant 25:e14077. https://doi.org/10.1111/petr.14077

Article  CAS  PubMed  Google Scholar 

Khush KK, Patel J, Pinney S et al (2019) Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: a prospective multicenter study. Am J Transplant 19:2889–2899. https://doi.org/10.1111/ajt.15339

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bloom RD, Bromberg JS, Poggio ED et al (2017) Cell-free DNA and active rejection in kidney allografts. J Am Soc Nephrol 28:2221–2232. https://doi.org/10.1681/ASN.2016091034

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jordan SC, Bunnapradist S, Bromberg JS, Langone AJ, Hiller D, Yee JP, Sninsky JJ, Woodward RN, Matas AJ (2018) Donor-derived cell-free DNA identifies antibody-mediated rejection in donor specific antibody positive kidney transplant recipients. Transplant Direct 4:e379. https://doi.org/10.1097/TXD.0000000000000821

Article  CAS  PubMed  PubMed Central  Google Scholar 

Puliyanda DP, Swinford R, Pizzo H, Garrison J, De Golovine AM, Jordan SC (2021) Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants. Pediatr Transplant 25:e13850. https://doi.org/10.1111/petr.13850

Article  CAS  PubMed  Google Scholar 

Dandamudi R, Gu H, Goss CW, Walther L, Dharnidharka VR (2022) Longitudinal evaluation of donor-derived cellfree DNA in pediatric kidney transplantation. Clin J Am Soc Nephrol 17:1646–1655. https://doi.org/10.2215/CJN.03840322

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ranch D, Fei M, Kincade E, Piburn K, Hitchman K, Klein K (2023) Utilization of donor-derived Cell-Free DNA in pediatric kidney transplant recipients: a single center study. Pediatr Transplant 28:e14582. https://doi.org/10.1111/petr.14582

Article  CAS  PubMed  Google Scholar 

Oellerich M, Sherwood K, Keown P, Schütz E, Beck J, Stegbauer J, Rump LC, Walson PD (2021) Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury. Nat Rev Nephrol 17:591–603. https://doi.org/10.1038/s41581-021-00428-0

Article  CAS  PubMed  Google Scholar 

Grskovic M, Hiller DJ, Eubank LA et al (2016) Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients. J Mol Diagn Meth 18:890–902. https://doi.org/10.1016/j.jmoldx.2016.07.003

Article  CAS  Google Scholar 

Wong L, Scott S, Grskovic M, Dholakia S, Woodward RN (2020) The evolution and innovation of donor-derived cell-free DNA testing in transplantation. J Med Diagn Meth 9:302. https://doi.org/10.35248/2168-9784.2020.9.302

Loupy A, Haas M, Roufosse C et al (2020) The Banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am J Transplant 20:2318–2331. https://doi.org/10.1111/ajt.15898

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pierce CB, Muñoz A, Ng DK, Warady BA, Furth SL, Schwartz GJ (2021) Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int 99:948–956. https://doi.org/10.1016/j.kint.2020.10.047

Article  CAS  PubMed  Google Scholar 

Lo YMD, Tein MSC, Pang CCP, Yeung CK, Tong KL, Magnus Hjelm N (1998) Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet 351:1329–1330. https://doi.org/10.1016/S0140-6736(05)79055-3

Article  CAS  PubMed  Google Scholar 

Bu L, Gupta G, Pai A et al (2022) Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study. Kidney Int 101:793–803. https://doi.org/10.1016/j.kint.2021.11.034

Article  CAS  PubMed  Google Scholar 

Stites E, Kumar D, Olaitan O et al (2020) High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury. Am J Transplant 20:2491–2498. https://doi.org/10.1111/ajt.15822

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wiebe C, Kosmoliaptsis V, Pochinco D et al (2019) HLA-DR/DQ molecular mismatch: a prognostic biomarker for primary alloimmunity. Am J Transplant 19:1708–1719. https://doi.org/10.1111/ajt.15177

Article  CAS  PubMed  Google Scholar 

Wiebe C, Gibson IW, Blydt-Hansen TD, Pochinco D, Birk PE, Ho J, Karpinski M, Goldberg A, Storsley L, Rush DN, Nickerson PW (2015) Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody. Am J Transplant 15:2921–2930. https://doi.org/10.1111/ajt.13347

Article  CAS  PubMed  Google Scholar 

Chua A, Cramer C, Moudgil A et al (2018) Kidney transplant practice patterns and outcome benchmarks over 30 years: the 2018 report of the NAPRTCS. Pediatr Transplant 23:e13597. https://doi.org/10.1111/petr.13597

Article  Google Scholar 

Gordillo R, Munshi R, Monroe EJ, Shivaram GM, Smith JM (2019) Benefits and risks of protocol biopsies in pediatric renal transplantation. Pediatr Nephrol 34:593–598. https://doi.org/10.1007/s00467-018-3959-6

Article  PubMed  Google Scholar 

Kanzelmeyer NK, Lerch C, Ahlenstiel-Grunow T, Bräsen JH, Haffner D, Pape L (2020) The role of protocol biopsies after pediatric kidney transplantation. Medicine (Baltimore) 99:e20522. https://doi.org/10.1097/MD.0000000000020522

Article  PubMed  PubMed Central  Google Scholar 

Halloran PF, Reeve J, Madill-Thomsen KS, Demko Z, Prewett A, Billings P (2022) The Trifecta study: comparing plasma levels of donor-derived cell-free DNA with the molecular phenotype of kidney transplant biopsies. J Am Soc Nephrol 33:387–400. https://doi.org/10.1681/ASN.2021091191

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gold A, Tönshoff B, Döhler B, Süsal C (2020) Association of graft survival with tacrolimus exposure and late intra-patient tacrolimus variability in pediatric and young adult renal transplant recipients—an international CTS registry analysis. Transpl Int 33:1681–1692. https://